A first-in-human study of CD123 NK cell engager SAR443579 in relapsed or refractory acute myeloid leukemia, B-cell acute lymphoblastic leukemia, or high-risk myelodysplasia.

被引：0
|
作者：
Stein, Anthony Selwyn
Jongen-Lavrencic, Mojca
Garciaz, Sylvain
Huls, Gerwin A.
Maiti, Abhishek
Boissel, Nicolas
De Botton, Stephane
Fleming, Shaun
Zwaan, C. Michel
de Leeuw, David C.
Desai, Pinkal
Arellano, Martha Lucia
Avigan, David
Langemeijer, Saskia
Jensen, Kyle A.
Wagenaar, Timothy
Mi, Gu
Abbadessa, Giovanni
Bajel, Ashish
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
[2] Erasmus MC, Rotterdam, Netherlands
[3] Aix Marseille Univ, Inst Paoli Calmettes, Marseille, France
[4] Univ Med Ctr Groningen, Groningen, Netherlands
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[6] Hop St Louis, Paris, France
[7] Inst Gustave Roussy, Paris, France
[8] Alfred Hlth, Melbourne, Australia
[9] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands
[10] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[11] Weill Cornell Med, New York, NY USA
[12] Emory Univ, Atlanta, GA USA
[13] Beth Israel Deaconess Med Ctr, Boston, MA USA
[14] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
[15] Sanofi, Cambridge, MA USA
[16] Peter MacCallum Canc Ctr, Melbourne, Australia
[17] Royal Melbourne Hosp, Melbourne, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7005
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Tisagenlecleucel for treatment of children and young adults with relapsed/refractory B-cell acute lymphoblastic leukemia
    Si Lim, Stephanie J.
    Grupp, Stephen A.
    DiNofia, Amanda M.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (09)
  • [32] Inotuzumab Ozogamicin Salvage Monotherapy for the Treatment of Relapsed/Refractory Acute B-Cell Lymphoblastic Leukemia
    Darcin, Tahir
    Yigenoglu, Tugce Nur
    Sahin, Derya
    Bakirtas, Mehmet
    Basci, Semih
    Merdin, Alparslan
    Yildiz, Jale
    Ulu, Bahar Uncu
    Tetik, Aysegul
    Iskender, Dicle
    Cakar, Merih Kizil
    Dal, Mehmet Sinan
    Altuntas, Fevzi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S192 - S193
  • [33] Developing a mechanistic translational PK/PD model for a trifunctional NK cell engager to predict the first-in-human dose for acute myeloid leukemia
    Choi, Siak-Leng
    Valente, Delphine
    Virone-Oddos, Angela
    Mauriac, Christine
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (01):
  • [34] First-In-Human Study of a Trail Receptor Agonist Fusion Protein, Eftozanermin Alfa, in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Diffuse Large B-Cell Lymphoma
    Jongen-Lavrencic, Mojca
    Yuda, Junichiro
    Mous, Rogier
    Olszewski, Adam
    Nijland, Marcel
    Abedin, Sameem
    Calvo, Emiliano
    Nuthalapati, Silpa
    Motwani, Monica
    Modi, Dimple
    Mu, Yunming
    Petrich, Adam M.
    Penugonda, Sudhir
    Morillo, Daniel
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S177 - S177
  • [35] A phase I study of the combination of palbociclib and dexamethasone for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia
    Wilde, Lindsay
    Porazzi, Patrizia
    Trotta, Rossana
    De Dominici, Marco
    Palmisiano, Neil
    Keiffer, Gina
    Rancani, Kaitlin
    Yingling, Kathryn
    Calabretta, Bruno
    Kasner, Margaret
    LEUKEMIA RESEARCH, 2023, 129
  • [36] TARGETING BONE MARROW MICROENVIRONMENT FOR TREATMENT OF HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Cheung, Laurence
    Lock, Richard
    Kuek, Vincent
    Kotecha, Rishi
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [37] TARGETING BONE MARROW MICROENVIRONMENT FOR TREATMENT OF HIGH-RISK B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Cheung, Laurence
    Lock, Richard
    Kuek, Vincent
    Kotecha, Rishi
    EXPERIMENTAL HEMATOLOGY, 2024, 137
  • [38] Targeting Bone Marrow Microenvironment for Treatment of High-Risk B-Cell Acute Lymphoblastic Leukemia
    Cheung, Laurence C.
    Trinder, Sarah
    Hughes, Anastasia
    Mullin, Benjamin
    Rashid, Sarah
    Yuan, Jinbo
    Xu, Jiake
    Duncan, Owen
    Lock, Richard B.
    Malinge, Sebastien
    Kuek, Vincent
    Kotecha, Rishi Sury
    BLOOD, 2023, 142
  • [39] Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia
    Mueller, Karen Thudium
    Maude, Shannon L.
    Porter, David L.
    Frey, Noelle
    Wood, Patricia
    Han, Xia
    Waldron, Edward
    Chakraborty, Abhijit
    Awasthi, Rakesh
    Levine, Bruce L.
    Melenhorst, J. Joseph
    Grupp, Stephan A.
    June, Carl H.
    Lacey, Simon F.
    BLOOD, 2017, 130 (21) : 2317 - 2325
  • [40] Targeting SF3B1 in High-Risk B-Cell Acute Lymphoblastic Leukemia
    Murakami, Yuki
    Konishi, Hiroaki
    Tepper, Cliff
    McPherson, John
    Satake, Noriko
    BLOOD, 2023, 142
12345